FAB

Recent Finacing

Seed

Recent Raise

Undisclosed

FAB develops small-molecule therapeutics that reduce age-associated chemical damage, testing proprietary compounds in vitro and in disease-relevant models to treat age-related conditions including arthritis, sarcopenia, and Alzheimer's.